Results 181 to 190 of about 1,841 (205)
Some of the next articles are maybe not open access.
The effect of ribavirin dosage on the kinetics of viral load decline and drug exposures in plasma and liver with OBV/PTV/r + DSV treatment in patients with chronic hepatitis C virus genotype 1a infection
Journal of Hepatology, 2017 A.H. Talal, E.O. Dumas, B. Bauer, R.M. Rejman, A. Ocque, G.D. Morse, D. Lucic, G.A. Cloherty, J. King, H. Zhang, D.E. Cohen, N. Shulman, J.-M. Pawlotsky, C. Hézode +13 moreopenaire +1 more sourcePrevalence and Management of Drug-Drug Interactions (DDIs) with Ombitasvir (OBV), Paritaprevir/R (PRV/r) ± Dasabuvir (DBV) ± Ribavirin (RBV) in Pacients with Chronic Hepatitis C in Real-Life Clinical Practice
Journal of Hepatology, 2016 E. González-Colominas, M.-C. Londoño, R.M. Morillas, X. Torras, S. Mojal, S. Lens, D. López, A. Gallego, Z. Mariño, M. Ardèvol, N. Pagès, R. Solà, J.A. Carrión +12 moreopenaire +1 more sourceEffectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study
Journal of Hepatology, 2017 M.-C. Londoño, L. Garcia-Buey, J. Mallolas, G. Barril, A. Ahumada, M. Riveiro-Barciela, R. Muñoz-Gomez, M. Roget, M.A. Serra, M.J. Devesa, C. Navascues, C. Baliellas, T. Aldamiz-Echevarria, M.L. Gutierrez, I. Carmona, B. Polo-Lorduy, L. Bonet, J. Garcia-Samaniego, M. Jiménez, M. Prieto, S. Moran, A. Castro, M. Delgado, F. Gea, I. Martin-Granizo, M. Montes, L. Morano, M.A. Castaño, I. De los Santos, M. Laguno, J.E. Losa, M. Montero, A. Rivero, A. Manzanares, C. De Alvaro +34 moreopenaire +1 more source